PRAX (Praxis Corp) Narxning prognoz qilingan daromadga nisbati
Noyob maqsadli epilepsiya dori vositalarining ishlab chiqilishi Praxis Precision Medicines (PRAX) kompaniyasiga yuqori narxlarni belgilash imkonini beradi. Kompaniyaning kutilayotgan P/S koeffitsiyenti bozor kutganlarini tasdiqlaydi va oxirgi ko'rsatkich 1210.80 darajasida turibdi. Barqaror boshqaruv R&D rejalarini aniq amalga oshirmoqda, garchi geosiyosiy keskinliklar va patent murakkabliklari global kengayish hamda xomashyo logistikasiga to'sqinlik qilishi mumkin bo'lsa-da.
Praxis Precision Medicines kompaniyasining tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- biznesning bozor baholash ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Praxis Precision Medicines|PRAX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Praxis Precision Medicines Inc|PRAX - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar Praxis Medicines|PRAX - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi Praxis Precision Medicines|Tezkor likvidlik praxismedicines.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
PRAX - Kompaniya foydasi|Kelajakdagi foyda Praxis Precision Medicines|PRAX - Kompaniya qiymatining sof foydaga nisbati|Kelajakdagi narxning foydaga nisbati praxismedicines.com|PRAX - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Praxis Corp|PRAX - Foizlar, soliqlar va eskirishdan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Praxis Precision Medicines|PRAX - So'nggi 12 oy davomida bir aksiya uchun foyda|Choraklik EPS foyda o'sishi praxismedicines.com|PRAX - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Praxis Precision Medicines
- tushum va sotuvlar tafsilotlari:
Kompaniyaning har tomonlama tahlili:Praxis Corp PRAX
Portfel menejerlari Praxis Precision Medicines (PRAX) kompaniyasining operatsion modelini kelajakdagi pul oqimlari prizmasi orqali baholaydilar. Ushbu ko'rsatkich kutilayotgan daromadning bir dollari bo'yicha bozor qiymatini o'lchaydi va choraklik hisobotlar orasidagi vaqt kechikishini neytrallashtiradi. Forward P/S koeffitsiyentini tahlil qilish orqali investorlar markaziy nerv tizimi (CNS) terapiyasi va genetik ishlanmalar salohiyatining joriy haddan ortiq baholanganligini ko'rishlari mumkin. Ushbu metrikaning barqarorligi kompaniyaning psixozlarni davolashdagi ilmiy asoslarining fundamental chidamliligini tasdiqlaydi.
Raqobatdosh kompaniyalar tahlili
Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|AVXL: Forvard P/S multiplikatori|CBLL (ceribell.com) - Narxning prognoz qilingan daromadga nisbati|PRTA (Prothena Corporation) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori alector.com (ALEC)|Narxning prognoz qilingan daromadga nisbati Annexon, Inc. (ANNX)|OMER - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Voyager Therapeutics Inc - Forvard P/S multiplikatori|Neumora (NMRA) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|TVGN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ACOG (Alpha Cognition Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori cogrx.com (CGTX)|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cassava Sciences|Forvard P/S multiplikatori ASRT (Assertio Holdings)|COYA - Forvard narx/daromad multiplikatori|vistagen.com - Forvard P/S multiplikatori|OVID: Narxning prognoz qilingan daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning prognoz qilingan daromadga nisbati|CervoMed Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PEPG (PepGen Inc)|Forvard P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori
